- Home
- DNLI vs MAT Comparison
DNLI vs MAT Comparison
Compare DNLI & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | MAT |
|---|---|---|
| Founded | 2013 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.2B |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DNLI | MAT |
|---|---|---|
| Price | $24.92 | $14.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $34.33 | $20.90 |
| AVG Volume (30 Days) | 1.3M | ★ 3.6M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $5,347,623,000.00 |
| Revenue This Year | N/A | $5.92 |
| Revenue Next Year | $408.85 | $5.08 |
| P/E Ratio | ★ N/A | $105.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.58 | $12.73 |
| 52 Week High | $27.30 | $22.48 |
Technical Indicators
Market Signals| Indicator | DNLI | MAT |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 48.51 |
| Support Level | $22.32 | $14.11 |
| Resistance Level | $25.74 | $15.33 |
| Average True Range (ATR) | 0.83 | 0.47 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 62.75 | 22.04 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.